Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.

MLA

Kawamura, Natsumi, et al. “Blockade of NF-KappaB Improves Cardiac Function and Survival without Affecting Inflammation in TNF-Alpha-Induced Cardiomyopathy.” Cardiovascular Research, vol. 66, no. 3, June 2005, pp. 520–29. EBSCOhost, https://doi.org/10.1016/j.cardiores.2005.02.007.

APA

Kawamura, N., Kubota, T., Kawano, S., Monden, Y., Feldman, A. M., Tsutsui, H., Takeshita, A., & Sunagawa, K. (2005). Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. Cardiovascular Research, 66(3), 520–529. https://doi.org/10.1016/j.cardiores.2005.02.007

Chicago

Kawamura, Natsumi, Toru Kubota, Shunichi Kawano, Yoshiya Monden, Arthur M Feldman, Hiroyuki Tsutsui, Akira Takeshita, and Kenji Sunagawa. 2005. “Blockade of NF-KappaB Improves Cardiac Function and Survival without Affecting Inflammation in TNF-Alpha-Induced Cardiomyopathy.” Cardiovascular Research 66 (3): 520–29. doi:10.1016/j.cardiores.2005.02.007.